Kivenul

Ibuprofen/Paracetamol, the active ingredient in Kivenul, is an analgesic presented as an oral tablet for adult use. It provides pain relief and fever reduction in patients requiring combined analgesic and antipyretic therapy.

GNH USA supplies Kivenul as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kivenul, a combined ibuprofen and paracetamol formulation, acts on inflammatory and pain pathways to relieve various conditions.

- Pain relief: reduces mild to moderate pain such as headache or muscle aches. - Fever reduction: lowers elevated body temperature in febrile states. - Headache: alleviates tension‑type and migraine‑associated headache. - Musculoskeletal pain: eases discomfort from strains, sprains, arthritis or other joint conditions.

Kivenul may cause adverse reactions ranging from mild to serious; the frequency and severity depend on individual susceptibility and dosage.

Common Side Effects: - Nausea or dyspepsia. - Dizziness or light‑headedness. - Mild skin rash or itching. - Elevated liver enzymes (occasionally).

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis or angioedema. - Gastrointestinal bleeding, ulceration or perforation. - Hepatotoxicity, especially with overdose or chronic high‑dose use. - Renal impairment in susceptible patients.

When using Kivenul, consider the following precautions: - Assess liver function: monitor hepatic enzymes in patients with existing liver disease. - Evaluate renal function: avoid or adjust use in severe renal impairment. - Avoid in known hypersensitivity: do not use if the patient is allergic to ibuprofen, other NSAIDs, or paracetamol. - Use with caution in cardiovascular disease: monitor blood pressure and heart failure status. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Kivenul can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - High‑dose paracetamol products: risk of hepatotoxicity. - Lithium: ibuprofen may raise lithium serum levels. - Methotrexate: ibuprofen can reduce methotrexate clearance.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: increased risk of renal impairment. - SSRIs: additive bleeding risk. - Alcohol: enhanced liver toxicity. - Asthma: ibuprofen may trigger bronchospasm in susceptible individuals.